Authors:
GODWIN JE
KOPECKY KJ
HEAD DR
WILLMAN CL
LEITH CP
HYNES HE
BALCERZAK SP
APPELBAUM FR
Citation: Je. Godwin et al., A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY (9031), Blood, 91(10), 1998, pp. 3607-3615
Authors:
MORROW GR
ROSCOE JA
HYNES HE
FLYNN PJ
PIERCE HI
BURISH T
Citation: Gr. Morrow et al., PROGRESS IN REDUCING ANTICIPATORY NAUSEA AND VOMITING - A STUDY OF COMMUNITY PRACTICE, Supportive care in cancer, 6(1), 1998, pp. 46-50
Authors:
RUSSELL CA
GREEN SJ
OSULLIVAN J
HYNES HE
BUDD GT
CONGDON JE
MARTINO S
OSBORNE CK
Citation: Ca. Russell et al., MEGESTROL-ACETATE AND AMINOGLUTETHIMIDE HYDROCORTISONE IN SEQUENCE ORIN COMBINATION AS 2ND-LINE ENDOCRINE THERAPY OF ESTROGEN RECEPTOR-POSITIVE METASTATIC BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP PHASE-III TRIAL/, Journal of clinical oncology, 15(7), 1997, pp. 2494-2501
Authors:
WEICK JK
KOPECKY KJ
APPELBAUM FR
HEAD DR
KINGSBURY LL
BALCERZAK SP
BICKERS JN
HYNES HE
WELBORN JL
SIMON SR
GREVER M
Citation: Jk. Weick et al., A RANDOMIZED INVESTIGATION OF HIGH-DOSE VERSUS STANDARD-DOSE CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Blood, 88(8), 1996, pp. 2841-2851
Authors:
GODWIN JE
KOPECKY KJ
HEAD DR
HYNES HE
BALCERZAK SP
APPELBAUM FR
Citation: Je. Godwin et al., A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Blood, 86(10), 1995, pp. 1723-1723
Authors:
ATIBA JO
GREEN SJ
HYNES HE
OSBORNE CK
MILLER TP
DAVIDNER M
Citation: Jo. Atiba et al., PHASE-II EVALUATION OF MITOXANTRONE PLUS CISPLATINUM IN PATIENTS WITHADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 12(2), 1994, pp. 129-132
Authors:
DAKHIL SR
HYNES HE
CANNON MW
JOHNSON DB
MOORE DF
Citation: Sr. Dakhil et al., G-CSF PLUS CIPROFLOXACIN IN THE PREVENTION OF SEPSIS IN PATIENTS WITHSEVERE NEUTROPENIA RELATED TO CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000024-10000024
Authors:
MOORE DF
MOORE DF
JOHNSON DB
CANNON MW
WHISMAN SA
CHURCH PS
PALCO W
DAKHIL S
HYNES HE
Citation: Df. Moore et al., BETHESDA UNIT TITER AS A PROGNOSTIC FACTOR FOR PATIENTS WITH ACQUIREDFACTOR-VIII INHIBITORS, Blood, 84(10), 1994, pp. 10000680-10000680
Authors:
MARSHALL ME
WOLF MK
CRAWFORD ED
TAYLOR S
BLUMENSTEIN B
FLANIGAN R
MEYERS FJ
HYNES HE
BARLOGIE B
EISENBERGER M
Citation: Me. Marshall et al., PHASE-II TRIAL OF ECHINOMYCIN FOR THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 11(2-3), 1993, pp. 207-209
Authors:
CHAPMAN R
CROWLEY J
LUCAS J
HOM BL
LIVINGSTON RB
VAUGHN CB
HYNES HE
Citation: R. Chapman et al., MITOGAUZONE, CISPLATIN, AND VINBLASTINE IN ADVANCED NONSMALL CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 11(1), 1993, pp. 91-92